Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer of Brain and Nervous System”

2,887 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,887 results

Testing effectiveness (Phase 2)Study completedNCT00091182
What this trial is testing

Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Extragonadal Germ Cell TumorChildhood Hepatoblastoma+23 more
National Cancer Institute (NCI) 180
Not applicableUnknownNCT05981170
What this trial is testing

Rurality Adapted Physical Activity Sport Health

Who this might be right for
Brain TumourMetastatic Cancer
Institut Cancerologie de l'Ouest 10
Testing effectiveness (Phase 2)Study completedNCT01067469
What this trial is testing

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Brain CancerGlioblastoma
M.D. Anderson Cancer Center 83
Testing effectiveness (Phase 2)Study completedNCT02312622
What this trial is testing

Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer

Who this might be right for
Stage IV Non-small Cell Lung Cancer (NSCLC)Recurrent Non-small Cell Lung Cancer (NSCLC)Extensive-stage Small Cell Lung Cancer (SCLC)+3 more
Joel Neal 27
Not applicableLooking for participantsNCT05831631
What this trial is testing

Characterization of Circulating and Tumor-infiltrating Immune Cells in Malignant Brain Tumors

Who this might be right for
Brain Tumor, PrimaryBrain Tumor - Metastatic
Pietro Mortini, MD, Prof. 200
Early research (Phase 1)Active Not RecruitingNCT02191488
What this trial is testing

ALA-induced PpIX Fluorescence During Brain Tumor Resection

Who this might be right for
Brain Tumors
David W. Roberts 540
Not applicableLooking for participantsNCT00001595
What this trial is testing

An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

Who this might be right for
PanhypopituitarismGigantism/AcromegalyProlactinoma+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 2,000
Testing effectiveness (Phase 2)Ended earlyNCT00910039
What this trial is testing

Sunitinib Malate After Stereotactic Radiosurgery in Treating Patients With Newly Diagnosed Brain Metastases

Who this might be right for
Cognitive/Functional EffectsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 14
Very early researchStudy completedNCT05704933
What this trial is testing

Pilot Study of Nivolumab w/Ipilimumab or Relatlimab in Surgically Resectable Melanoma Brain Metastases

Who this might be right for
Metastatic MelanomaMetastasis to Brain
H. Lee Moffitt Cancer Center and Research Institute 1
Early research (Phase 1)Study completedNCT00594633
What this trial is testing

Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors

Who this might be right for
Brain TumorBrain CancerCns Cancer+1 more
Memorial Sloan Kettering Cancer Center 25
Large-scale testing (Phase 3)Active Not RecruitingNCT04739761
What this trial is testing

T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 506
Testing effectiveness (Phase 2)Study completedNCT01189266
What this trial is testing

Vorinostat and Radiation Therapy Followed by Maintenance Therapy With Vorinostat in Treating Younger Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaDiffuse Intrinsic Pontine Glioma+1 more
National Cancer Institute (NCI) 79
Not applicableStudy completedNCT01764529
What this trial is testing

Modifiers of Disease Severity in Cerebral Cavernous Malformations

Who this might be right for
Cavernous Angioma, FamilialCerebral Cavernous MalformationsCerebral Cavernous Hemangioma
University of California, San Francisco 789
Not applicableEnded earlyNCT05891002
What this trial is testing

Accuracy of Robotically Assisted Cranial Biopsies

Who this might be right for
Intracranial Neoplasm
Brainlab AG 4
Testing effectiveness (Phase 2)Ended earlyNCT01065805
What this trial is testing

Demonstrate the Safety and Preliminary Efficacy of 18F-FLT in Patients With Solid Tumours or Lymphoma

Who this might be right for
Brain CancerCancerSolid Tumor+1 more
AHS Cancer Control Alberta 94
Testing effectiveness (Phase 2)Study completedNCT02858895
What this trial is testing

Convection-Enhanced Delivery (CED) of MDNA55 in Adults With Recurrent or Progressive Glioblastoma

Who this might be right for
GlioblastomaGrade IV AstrocytomaGlioblastoma Multiforme+1 more
Medicenna Therapeutics, Inc. 47
Not applicableStudy completedNCT00213876
What this trial is testing

Research of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain Tumours

Who this might be right for
Oligodendrogliomas
University Hospital, Strasbourg, France 189
Testing effectiveness (Phase 2)Ended earlyNCT03930771
What this trial is testing

Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas

Who this might be right for
Recurrent Pituitary Adenomas
Weill Medical College of Cornell University 1
Early research (Phase 1)Study completedNCT00003409
What this trial is testing

Motexafin Gadolinium Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center
Not applicableLooking for participantsNCT05124912
What this trial is testing

REMASTer: REcurrent Brain Metastases After SRS Trial

Who this might be right for
Brain MetastasesRadiation NecrosisRecurrent Tumor+1 more
Monteris Medical 261
Next Page